MARKER THERAPEUTICS, INC. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
MARKER THERAPEUTICS, INC. (MRKR) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 0 shares for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-23.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2018-03-23
- MARKER THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2017-09-30 was 0.00 shares.
- MARKER THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2017-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- MARKER THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2016-09-30 was 0.00 shares.
- MARKER THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2016-06-30 was 565.42K shares.
- MARKER THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2017 was 0.00 shares, a 100.00% decline from fiscal 2016.
- MARKER THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2016 was 531.10K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|
| 2017-12-31 | 0.00 shares 10-K · filed 2018-03-23 | |||
| 2017-09-30 | 0.00 shares 10-Q · filed 2017-11-14 | 0.00 shares 10-Q · filed 2017-11-14 | ||
| 2017-06-30 | 0.00 shares 10-Q · filed 2017-08-07 | 0.00 shares 10-Q · filed 2017-08-07 | ||
| 2016-12-31 | 531.10K shares 10-K · filed 2018-03-23 | |||
| 2016-09-30 | 0.00 shares 10-Q · filed 2017-11-14 | 565.00K shares 10-Q · filed 2017-11-14 | ||
| 2016-06-30 | 565.42K shares 10-Q · filed 2017-08-07 | 743.50K shares 10-Q · filed 2017-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |